Home News The race for the anti-Covid pill has begun: what we know about the new drug and how effective it is

The race for the anti-Covid pill has begun: what we know about the new drug and how effective it is

by admin

Waiting for Europe to strike a blow between the individual states, the race for the preventive purchase of the new anti-Covid pill by the American multinational Merck Sharp & Dohme (Msd) has begun, which requested and obtained from the EMA the expedited procedure of approval.

That rolling review that, by allowing you to analyze the results of clinical trials as they arrive, usually allows you to cross the approval line in two or three months at the most.

Ma

This article is reserved for those with a subscription

All the contents of the site

1 € per month for 3 months then 2.99 € per month for 3 months

Activate Now

We Messaggero Veneto the community of readers

.

See also  Court of Auditors: "We need a profound review of the collection"
0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy